Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Y Aoki

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Infection|January 1, 1987
Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitisR J Whitley, C A Alford, M S Hirsch, et al.
Military Medicine|September 1, 1986
Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980-1983F Y Aoki, H G Stiver, D S Sitar, et al.
The New England Journal of Medicine|January 16, 1986
Vidarabine versus acyclovir therapy in herpes simplex encephalitisR J Whitley, C A Alford, M S Hirsch, et al.
The Journal of Infectious Diseases|July 1, 1997
Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trialS D Shafran, S L Sacks, F Y Aoki, et al.
The Journal of Infectious Diseases|January 7, 1998
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
The New England Journal of Medicine|September 26, 1997
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study GroupF G Hayden, A D Osterhaus, J J Treanor, et al.
AIDS (London, England)|April 24, 2001
Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcersK S MacDonald, I Malonza, D K Chen, et al.
Burns : Journal of the International Society for Burn Injuries|October 16, 2001
An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipmentJ M Embil, J A McLeod, A M Al-Barrak, et al.
Lancet (London, England)|July 10, 2009
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenJ Paavonen, P Naud, J Salmerón, et al.
International Journal of Cancer|August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18A Szarewski, W A J Poppe, S R Skinner, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Infection|January 1, 1987
Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitisR J Whitley, C A Alford, M S Hirsch, et al.
Military Medicine|September 1, 1986
Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980-1983F Y Aoki, H G Stiver, D S Sitar, et al.
The New England Journal of Medicine|January 16, 1986
Vidarabine versus acyclovir therapy in herpes simplex encephalitisR J Whitley, C A Alford, M S Hirsch, et al.
The Journal of Infectious Diseases|July 1, 1997
Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trialS D Shafran, S L Sacks, F Y Aoki, et al.
The Journal of Infectious Diseases|January 7, 1998
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
The New England Journal of Medicine|September 26, 1997
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study GroupF G Hayden, A D Osterhaus, J J Treanor, et al.
AIDS (London, England)|April 24, 2001
Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcersK S MacDonald, I Malonza, D K Chen, et al.
Burns : Journal of the International Society for Burn Injuries|October 16, 2001
An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipmentJ M Embil, J A McLeod, A M Al-Barrak, et al.
Lancet (London, England)|July 10, 2009
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenJ Paavonen, P Naud, J Salmerón, et al.
International Journal of Cancer|August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18A Szarewski, W A J Poppe, S R Skinner, et al.
Pageof 8